Research Progress of Cordyceps sinensis and Its Fermented Mycelium Products on Ameliorating Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition

References

• Humphreys BD. Mechanisms of renal fibrosis. Annu Rev Physiol. 2018;80(1):309–326.
   PubMedGoogle Scholar
• Yuan Q, Liu Y. Recent advances on understanding of the cellular and molecular mechanism of renal fibrosis. J Anhui Univ. 2018;42(5):115–124.
   Google Scholar
• Klinkhammer BM, Goldschmeding R, Floege J, Boor P. Treatment of renal fibrosis-turning challenges into opportunities. Adv Chronic Kidney Dis. 2017;24(2):117–129.
   PubMed Web of Science ®Google Scholar
• Yan H, Xu J, Xu Z, Yang B, Luo P, He Q. Defining therapeutic targets for renal fibrosis: exploiting the biology of pathogenesis. Biomed Pharmacother. 2021;143:112115.
   PubMed Web of Science ®Google Scholar
• Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124(6):2299–2306.
   PubMed Web of Science ®Google Scholar
• Mack M, Yanagita M. Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int. 2015;87(2):297–307.
   PubMed Web of Science ®Google Scholar
• Sun YB, Qu X, Caruana G, Li J. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. Differentiation. 2016;92(3):102–107.
   PubMed Web of Science ®Google Scholar
• Djudjaj S, Boor P. Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med. 2019;65:16–36.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin D, Kang X, et al. Signaling pathways involved in diabetic renal fibrosis. Front Cell Dev Biol. 2021;9:696542.
   PubMed Web of Science ®Google Scholar
• Wang S, Meng XM, Ng YY, et al. TGF-beta/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis. Oncotarget. 2016;7(8):8809–8822.
   PubMedGoogle Scholar
• Grande MT, Sánchez-Laorden B, López-Blau C, et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015;21(9):989–997.
   PubMed Web of Science ®Google Scholar
• Lovisa S, LeBleu VS, Tampe B, et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21(9):998–1009.
   PubMed Web of Science ®Google Scholar
• Sheng L, Zhuang S. New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis. Front Physiol. 2020;11:569322.
   PubMed Web of Science ®Google Scholar
• Meng XM, Tang PM, Li J, Lan HY. TGF-beta/Smad signaling in renal fibrosis. Front Physiol. 2015;6:82.
   PubMed Web of Science ®Google Scholar
• Tan RJ, Zhou D, Zhou L, Liu Y. Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl. 2014;4(1):84–90.
   PubMed Web of Science ®Google Scholar
• Campbell MT, Hile KL, Zhang H, et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res. 2011;168(1):e61–e69.
   PubMed Web of Science ®Google Scholar
• Chen KH, Hsu HH, Yang HY, et al. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway. Int J Biochem Cell Biol. 2016;74:135–144.
   PubMed Web of Science ®Google Scholar
• Zhang F, Liu H, Liu D, et al. Effects of RAAS inhibitors in patients with kidney disease. Curr Hypertens Rep. 2017;19(9):72.
   PubMed Web of Science ®Google Scholar
• Wang DT, Huang RH, Cheng X, Zhang ZH, Yang YJ, Lin X. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats. Int Immunopharmacol. 2015;26(1):4–12.
   PubMed Web of Science ®Google Scholar
• Zhang HF, Wang YL, Gao C, et al. Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats. Acta Pharmacol Sin. 2018;39(12):1855–1864.
   PubMed Web of Science ®Google Scholar
• Zhou S, Ai Z, Li W, et al. Deciphering the pharmacological mechanisms of taohe-chengqi decoction extract against renal fibrosis through integrating network pharmacology and experimental validation in vitro and in vivo. Front Pharmacol. 2020;11:425.
   PubMed Web of Science ®Google Scholar
• Tan W, Wang Y, Dai H, et al. Potential therapeutic strategies for renal fibrosis: cordyceps and related products. Front Pharmacol. 2022;13:932172.
   PubMed Web of Science ®Google Scholar
• Zhang HW, Lin ZX, Tung YS, et al. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev. 2014;2(12):D8353.
   Google Scholar
• Li Y, Xu G. Clinical Efficacy and Safety of Jinshuibao Combined With ACEI/ARB in the Treatment of Diabetic Kidney Disease: a Meta-Analysis of Randomized Controlled Trials. J Ren Nutr. 2020;30(2):92–100.
   PubMed Web of Science ®Google Scholar
• Lu Q, Li C, Chen W, Shi Z, Zhan R, He R. Clinical efficacy of jinshuibao capsules combined with angiotensin receptor blockers in patients with early diabetic nephropathy: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:6806943.
   PubMed Web of Science ®Google Scholar
• Zhang M, Gao X, Zhang L. Efficacy of Jinshuibao capsule combined with prednisone in early aristolochic acid nephropathy. Capital Med. 2009;16(16):46–47.
   Google Scholar
• Huang J, Li J, Liu T. Effect of combined therapy with hypha Cordyceps and ginkgo leaf tablet on micro-inflammation in patients undergoing maintenance hemodialysis. Chin J Integrated Traditional Western Med. 2008;28(6):502–504.
   Google Scholar
• Yu W, Duan S, Yu Z. The effect of Bailing capsules combined with losartan to treat diabetic glomerulosclerosis and the combination’s effect on blood and urine biochemistry. Am J Transl Res. 2021;13(6):6873–6880.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Shi L. Influence of bailing capsules and alprostadil on inflammatory factors, liver and renal function in patients with diabetic nephropathy. Western J Traditional Chine Med. 2022;35(06):115–117.
   Google Scholar
• Liu Z, Gao B, Li X. Efficacy of the Bailing capsules plus enalapril maleate on chronic glomerulonephritis. Clin J Chine Med. 2022;14(14):115–118.
   Google Scholar
• Zhang L. Analysis of the effect of Baling capsule combined with cyclophosphamide in treating chronic glomerulonephritis. Practical Integrated Chine Western Med. 2021;21(06):77–78.
   Google Scholar
• Hu X, Cui B, Gao Q, Wang Z, Liu Y. Meta-analysis of Bailing Capsules in improvement of microinflammation and nutritional status among maintenance hemodialysis patients. China J Chine Materia Med. 2022;47(9):2547–2555.
   Google Scholar
• Zhi Y, Wei Z, Cao Y. Effect of Bailing Capsules combined with a comprehensive intervention on the renal fibrosis and renal function in patients with chronic renal failure. J Changchun Univ Chine Med. 2022;38(02):213–216.
   Google Scholar
• Wang W, Qi J. Clinical study of Zhiling Capsule combined with telmisartan in treatment of early diabetic nephropathy. Drugs Clin. 2018;33(06):1494–1497.
   Google Scholar
• Wu H, Tu B. Clinical study on Zhiling Capsules combined with benazepril in treatment of chronic glomerulonephritis. Drugs Clin. 2019;34(06):1789–1792.
   Google Scholar
• Jin Y, Zou D, Liu S. Clinical study of zhiling combined with compound α -ketoacid for chronic renal failure. Drugs Clin. 2022;37(04):813–817.
   Google Scholar
• Xu X, Jin L. Curative effect of Zhiling capsule combined Valsartan on chronic nephropathy and its influence on renal function. Chine J General Practice. 2016;14(12):2051–2054.
   Google Scholar
• Shi Y, Wei Z, Qiao S. The effect of Ning Xinbao for early kidney injury in diabetes mellitus. Shandong Med. 2004;44(35):10–11.
   Google Scholar
• Zhang G, Wang W. Clinical observation of treatment of diabetic nephropathy with Xinganbao capsule. Med J Chine Peoples Health. 2015;27(10):80–101.
   Google Scholar
• Chang X, Wang J, Wang N. The curative effect of xinganbao combined with losartan in 23 cases of IgA nephropathy. Chine J Integrated Traditional Chine Western Med Nephropathy. 2012;13(04):349–350.
   Google Scholar
• Ashraf SA, Elkhalifa A, Siddiqui AJ, et al. Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic cordyceps medicinal fungus and its nutraceutical and therapeutic potential. Molecules. 2020;25(12):2735.
   PubMed Web of Science ®Google Scholar
• Liu W, Gao Y, Zhou Y, Yu F, Li X, Zhang N. Mechanism of cordyceps sinensis and its extracts in the treatment of diabetic kidney disease: a review. Front Pharmacol. 2022;13:881835.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Y, Mi J, et al. GC-MS profiling of volatile components in different fermentation products of cordyceps sinensis mycelia. Molecules. 2017;22(10):54.
   Web of Science ®Google Scholar
• Olatunji OJ, Tang J, Tola A, Auberon F, Oluwaniyi O, Ouyang Z. The genus Cordyceps: an extensive review of its traditional uses, phytochemistry and pharmacology. Fitoterapia. 2018;129:293–316.
   PubMed Web of Science ®Google Scholar
• Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75(11):1145–1152.
   PubMed Web of Science ®Google Scholar
• Martínez-Klimova E, Aparicio-Trejo OE, Tapia E, Pedraza-Chaverri J. Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomolecules. 2019;9(4):141.
   PubMed Web of Science ®Google Scholar
• Du F, Li S, Wang T, et al. Cordyceps sinensis attenuates renal fibrosis and suppresses BAG3 induction in obstructed rat kidney. Am J Transl Res. 2015;7(5):932–940.
   PubMed Web of Science ®Google Scholar
• Gu L, Bie R, Tu Y. Mechanisms of cordycepin on improving renal interstitial fibrosis via regulating eIF2α/TGF-β/Smad signaling pathway. China J Chine Materia Med. 2014;39(21):4096–4101.
   Google Scholar
• Zheng R, Zhu R, Li X, et al. N6-(2-Hydroxyethyl) Adenosine From Cordyceps cicadae Ameliorates Renal Interstitial Fibrosis and Prevents Inflammation via TGF-β1/Smad and NF-κB Signaling Pathway. Front Physiol. 2018;9:1229.
   PubMed Web of Science ®Google Scholar
• Hu X, Xu Y, Zhang Z, et al. TSC1 affects the process of renal ischemia-reperfusion injury by controlling macrophage polarization. Front Immunol. 2021;12:637335.
   PubMed Web of Science ®Google Scholar
• Ross EA, Devitt A, Johnson JR. Macrophages: the Good, the Bad, and the Gluttony. Front Immunol. 2021;12:708186.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453–461.
   PubMed Web of Science ®Google Scholar
• Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FR. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes. 2008;57(6):1439–1445.
   PubMed Web of Science ®Google Scholar
• Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27(2):195–207.
   PubMed Web of Science ®Google Scholar
• Yu SH, Dubey NK, Li WS, et al. Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice. PLoS One. 2016;11(11):e166342.
   Web of Science ®Google Scholar
• Dong Z, Sun Y, Wei G, Li S, Zhao Z. A nucleoside/nucleobase-rich extract from cordyceps sinensis inhibits the epithelial-mesenchymal transition and protects against renal fibrosis in diabetic nephropathy. Molecules. 2019;24(22):4119.
   PubMed Web of Science ®Google Scholar
• Yang J, Dong H, Wang Y, et al. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis. Int J Biol Macromol. 2020;163:442–456.
   PubMed Web of Science ®Google Scholar
• Wang C, Hou XX, Rui HL, et al. Artificially cultivated Ophiocordyceps sinensis alleviates diabetic nephropathy and its podocyte injury via inhibiting P2X7R expression and NLRP3 inflammasome activation. J Diabetes Res. 2018;1390418.
   PubMed Web of Science ®Google Scholar
• Yan LJ. The nicotinamide/streptozotocin rodent model of type 2 diabetes: renal pathophysiology and redox imbalance features. Biomolecules. 2022;12(9):141.
   PubMed Web of Science ®Google Scholar
• Cao T, Xu R, Xu Y, Liu Y, Qi D, Wan Q. The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro. Int Urol Nephrol. 2019;51(10):1883–1892.
   PubMed Web of Science ®Google Scholar
• Pan MM, Zhang MH, Ni HF, et al. Inhibition of TGF-β1/Smad signal pathway is involved in the effect of Cordyceps sinensis against renal fibrosis in 5/6 nephrectomy rats. Food Chem Toxicol. 2013;58:487–494.
   PubMed Web of Science ®Google Scholar
• Fei Z, Tang D. Effect of Bailing Capsule on renal connective tissue growth factor expression in a remnant kidney model. Chine J Biomed. 2008;3(2):105–109.
   Google Scholar
• Zhu R, Chen YP, Deng YY, et al. Cordyceps cicadae extracts ameliorate renal malfunction in a remnant kidney model. J Zhejiang Univ Sci B. 2011;12(12):1024–1033.
   PubMed Web of Science ®Google Scholar
• Guo S, Zhong F, Zhou Q, et al. Renal protective effect of Cordyceps sinensis on 5 /6 nephrectomy-induced renal fibrosis in rats. J Shanghai Jiaotong Univ. 2012;32(01):1–8.
   Google Scholar
• Zhang MH, Pan MM, Ni HF, et al. Effect of Cordyceps sinensis powder on renal oxidative stress and mitochondria functions in 5/6 nephrectomized rats. Chin J Integrated Traditional Western Med. 2015;35(4):443–449.
   Google Scholar
• Xu XY, Chai JJ, Chen YP, et al. Hirsutella sinensis Attenuates Aristolochic Acid-Induced Renal Tubular Epithelial-Mesenchymal Transition by Inhibiting TGF-β1 and Snail Expression. PLoS One. 2016;11(2):e149242.
   Web of Science ®Google Scholar
• Chai JJ, Chen YP, Rui HL. Effects of Hirsutella sinensis on TGF-beta1 and Snail expressions and transdifferentiation of tubular epithelial-myofibroblast in renal tissue of rats with chronic aristolochic acid nephropathy. Chin J Integrated Traditional Western Med. 2009;29(4):325–329.
   Google Scholar
• Zhu YF, Chen YP, Rui HL, Dong HR, Hu Z. Protective effects of Hirsutella sinensis on renal interstitial fibrosis: experiment with rat model of chronic aristolochic acid nephropathy. Chin Med J. 2007;87(38):2667–2671.
   Google Scholar
• Deng JS, Jiang WP, Chen CC, et al. Cordyceps cicadae Mycelia Ameliorate Cisplatin-Induced Acute Kidney Injury by Suppressing the TLR4/NF-κB/MAPK and Activating the HO-1/Nrf2 and Sirt-1/AMPK Pathways in Mice. Oxid Med Cell Longev. 2020;2020:7912763.
   PubMed Web of Science ®Google Scholar
• Li N, Chen X, Yang D, Zhao D, Bi L. Prevention and treatment of renal interstitial fibrosis by Bailing capsule in rats. Chine Med Herald. 2006;3(30):16–18.
   Google Scholar
• Huang YS, Wang X, Feng Z, et al. Cordyceps cicadae Prevents Renal Tubular Epithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in Hypertensive Renal Injury. Evid Based Complement Alternat Med. 2020;2020:7202519.
   PubMed Web of Science ®Google Scholar
• Cai Y, Feng Z, Jia Q, et al. Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy. Front Pharmacol. 2021;12:801094.
   PubMed Web of Science ®Google Scholar
• Li L, He D, Yang J, Wang X. Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression. J Pharmacol Sci. 2011;117(4):286–294.
   PubMed Web of Science ®Google Scholar
• Zhu R, Zheng R, Deng Y, Chen Y, Zhang S. Ergosterol peroxide from Cordyceps cicadae ameliorates TGF-β1-induced activation of kidney fibroblasts. Phytomedicine. 2014;21(3):372–378.
   PubMed Web of Science ®Google Scholar
• Gifford CC, Tang J, Costello A, et al. Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities. Clin Sci (Lond). 2021;135(2):275–303.
   PubMed Web of Science ®Google Scholar
• Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65–76.
   PubMed Web of Science ®Google Scholar
• Ma TT, Meng XM. TGF-β/Smad and Renal Fibrosis. Adv Exp Med Biol. 2019;1165:347–364.
   PubMed Web of Science ®Google Scholar
• Meng XM, Chung AC, Lan HY. Role of the TGF-β/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond). 2013;124(4):243–254.
   PubMed Web of Science ®Google Scholar
• Duan Y, Yang S, Chen B. Regulating effects of Cordyceps sinensis capsule and telmisartan tablets on renal tubular epithelial-mesenchymal transition in in diabetic nephropathy rats. Chin J Clin Pharmacol. 2016;32(23):2170–2173.
   Google Scholar
• Nguyen TQ, Goldschmeding R. Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm Res. 2008;25(10):2416–2426.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim SI, Choi ME. Therapeutic targets for treating fibrotic kidney diseases. Transl Res. 2015;165(4):512–530.
   PubMed Web of Science ®Google Scholar
• Zhu B, Chen C. Effect of artificial cordyceps sinensis on the transformed growth factor-β1 and connective tissue growth factor expression in interstitial fibrotic rats. Clin Rational Drug Use. 2011;4(33):11–12.
   Google Scholar
• Zhang L, Yan Y. Protective effect of Cordyceps sinensis on diabetic nephropathy in a rat model. Jiangxi Med J. 2014;49(11):1188–1192.
   Google Scholar
• Chen J, Yao W, Zhu S, Zhu H, Ye L. Cordyceps sinensis attenuates renal epithelial-mesenchymal-transition in diabetic mice vial TGF-β/Snail signal pathway. Clin J Med Officers. 2017;45(2):140–144.
   Google Scholar
• Li SS, Sun Q, Hua MR, et al. Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis. Front Pharmacol. 2021;12:719880.
   PubMed Web of Science ®Google Scholar
• Du Y, Liu Y, Lu S, Liu Y, Qi W, Fu Y. Effects of Cordyceps sinensis on expressions of DKK1 and β-catenin in diabetic rats. J Shandong Univ. 2012;50(06):26–30.
   Google Scholar
• Li Z, Liu X, Wang B, et al. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Nephrology. 2017;22(8):589–597.
   PubMed Web of Science ®Google Scholar
• Lan H. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 2011;7(7):1056–1067.
   PubMed Web of Science ®Google Scholar
• Xue YS, Enosi Tuipulotu D, Tan WH, et al. Emerging activators and regulators of inflammasomes and pyroptosis. Trends Immunol. 2019;40(11):1035–1052.
   PubMed Web of Science ®Google Scholar
• Wang MZ, Wang J, Cao DW, et al. Fucoidan alleviates renal fibrosis in diabetic kidney disease via inhibition of NLRP3 inflammasome-mediated podocyte pyroptosis. Front Pharmacol. 2022;790937.
   PubMed Web of Science ®Google Scholar
• Ram C, Gairola S, Syed AM, et al. Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice. Life Sci. 2022;298:120527.
   PubMed Web of Science ®Google Scholar